New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2014
10:18 EDTHNT, UAM, AET, CI, UNH, WLP, WCG, HUMCMS says Medicare Advantage reimbursement to rise in 2015
The Centers for Medicare & Medicaid Services announced Medicare Advantage and prescription drug rates for 2015. The agency estimated that its payments for Medicare Advantage beneficiaries would rise slightly, versus its previous estimate that such payments would fall. A Medicare Advantage Plan is a type of health plan offered by a private company that contracts with Medicare to provide subscribers with Part A and Part B benefits. WHAT'S NEW: CMS reimbursements for Medicare Advantage beneficiaries will rise 0.4%, CMS estimated, compared to a February proposal that contemplated a 1.9% cut. ANALYST REACTION: In a note to investors earlier today, FBR Capital analyst Steven Halper wrote that the final Medicare Advantage rates are a positive for health insurers with significant exposure to such plans. Companies in this category include Aetna (AET), Humana (HUM), and UnitedHealth (UNH), said Halper. He kept Outperform ratings on Aetna and United Health and a Market Perform rating on Humana. Another research firm, Leerink, said it views the "biggest positive" from the final rates that the CMS announced last night as the delay in the proposal to eliminate in home Health Risk Assessments to support reimbursement for high risk seniors. Leerink thinks the final rates are favorable for MA plans and estimates the positive impact in order: Humana, Universal American (UAM), WellCare (WCG), UnitedHealth, Cigna (CI), Aetna, Health Net (HNT) and WellPoint (WLP). PRICE ACTION: In early trading, Aetna rose fractionally to $72.70, UnitedHealth lost 0.6% to $80.59, Humana sank 1.8% to $109.95, and Universal American added 2c to $7.16.
News For AET;HUM;UNH;UAM;WCG;CI;HNT;WLP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 26, 2014
07:08 EDTUNHUnitedHealth to host investor conference
Subscribe for More Information
November 21, 2014
16:36 EDTAETMarket ends week higher as domestic data, foreign central banks boost shares
Subscribe for More Information
14:27 EDTAETAetna raises quarterly dividend 11%, authorizes additional $1B share buyback
Subscribe for More Information
14:26 EDTAETAetna raises quarterly dividend 11%, authorizes additional $1B share buyback
Subscribe for More Information
November 17, 2014
14:06 EDTHUMHumana to offer plans on 15 state ACA individual market exchanges in 2015
Subscribe for More Information
07:16 EDTAETMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 14, 2014
16:52 EDTCIGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
08:04 EDTWLPWellPoint, Boehringer Ingelheim announce first project under collaboration
Boehringer Ingelheim Pharmaceuticals, WellPoint and HealthCore, announced that the companies are commencing a research project to identify and address unmet medical needs across populations of mutual interest. The first stage of the project will focus on non-valvular atrial fibrillation and will examine disease prevalence, treatment complications, such as hospital readmissions, and the use of evidence-based guidelines. This project is the first under the parties’ five-year research collaboration agreement, signed earlier this year. Information gathered through the NVAF project is intended to provide the basis for the collaborative development of healthcare interventions, which can be evaluated within WellPoint’s affiliated health plans and provider networks.
November 13, 2014
16:40 EDTWCGPennant Capital reports 7.0% passive stake in WellCare
08:34 EDTHNTHealth Net Federal Services awarded contract by CDCR
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use